Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Bangladesh
· Delayed Price · Currency is BDT
9.20
+0.10 (1.10%)
At close: Dec 19, 2024
DSE: IBP Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2015 |
Cash & Equivalents | 10.48 | 11.3 | 28.69 | 35.59 | 13.84 | 160.58 | Upgrade
|
Cash & Short-Term Investments | 10.48 | 11.3 | 28.69 | 35.59 | 13.84 | 160.58 | Upgrade
|
Cash Growth | -38.24% | -60.60% | -19.38% | 157.17% | -91.38% | 75.15% | Upgrade
|
Accounts Receivable | 225.01 | 223.65 | 218.93 | 245.75 | 226.08 | 178.8 | Upgrade
|
Other Receivables | - | - | - | - | - | 1.24 | Upgrade
|
Receivables | 225.01 | 223.65 | 218.93 | 245.75 | 226.08 | 180.04 | Upgrade
|
Inventory | 177.47 | 178.61 | 181.09 | 202.09 | 190.29 | 202.87 | Upgrade
|
Other Current Assets | 118.69 | 117.63 | 110.18 | 125.23 | 182.25 | 223.73 | Upgrade
|
Total Current Assets | 531.65 | 531.2 | 538.89 | 608.67 | 612.46 | 767.22 | Upgrade
|
Property, Plant & Equipment | 1,326 | 1,345 | 1,355 | 1,295 | 1,127 | 818.52 | Upgrade
|
Total Assets | 1,858 | 1,876 | 1,894 | 1,904 | 1,739 | 1,586 | Upgrade
|
Accounts Payable | 0.59 | 0.83 | 0.93 | 0.62 | 0.37 | 6.11 | Upgrade
|
Accrued Expenses | 9.99 | 12.8 | 13.16 | 20.98 | 18.8 | 14.64 | Upgrade
|
Short-Term Debt | 35.01 | 43.61 | 75.36 | 84.94 | - | - | Upgrade
|
Current Income Taxes Payable | 53.16 | 52.46 | 50.88 | 50.72 | 107.77 | 123.62 | Upgrade
|
Other Current Liabilities | 15.1 | 15.1 | 13.88 | 13.11 | - | - | Upgrade
|
Total Current Liabilities | 113.85 | 124.8 | 154.2 | 170.36 | 126.95 | 144.36 | Upgrade
|
Long-Term Deferred Tax Liabilities | 137.05 | 129.14 | 114.56 | 108.18 | 94.72 | 66.76 | Upgrade
|
Total Liabilities | 250.9 | 253.95 | 268.76 | 278.54 | 221.67 | 211.12 | Upgrade
|
Common Stock | 1,162 | 1,162 | 1,162 | 1,137 | 1,115 | 1,023 | Upgrade
|
Retained Earnings | 445.15 | 459.77 | 462.98 | 488.05 | 402.53 | 351.63 | Upgrade
|
Shareholders' Equity | 1,607 | 1,622 | 1,625 | 1,625 | 1,518 | 1,375 | Upgrade
|
Total Liabilities & Equity | 1,858 | 1,876 | 1,894 | 1,904 | 1,739 | 1,586 | Upgrade
|
Total Debt | 35.01 | 43.61 | 75.36 | 84.94 | - | - | Upgrade
|
Net Cash (Debt) | -24.53 | -32.31 | -46.67 | -49.35 | 13.84 | 160.58 | Upgrade
|
Net Cash Growth | - | - | - | - | -91.38% | 75.15% | Upgrade
|
Net Cash Per Share | -0.22 | -0.28 | -0.40 | -0.43 | 0.12 | 1.60 | Upgrade
|
Filing Date Shares Outstanding | 116.21 | 116.21 | 116.21 | 113.74 | 113.67 | 113.74 | Upgrade
|
Total Common Shares Outstanding | 116.21 | 116.21 | 116.21 | 113.74 | 113.67 | 113.74 | Upgrade
|
Working Capital | 417.8 | 406.39 | 384.69 | 438.3 | 485.51 | 622.86 | Upgrade
|
Book Value Per Share | 13.83 | 13.96 | 13.98 | 14.29 | 13.35 | 12.09 | Upgrade
|
Tangible Book Value | 1,607 | 1,622 | 1,625 | 1,625 | 1,518 | 1,375 | Upgrade
|
Tangible Book Value Per Share | 13.83 | 13.96 | 13.98 | 14.29 | 13.35 | 12.09 | Upgrade
|
Land | - | 160.11 | 162.11 | 93.5 | 91.39 | 45.49 | Upgrade
|
Buildings | - | 236.17 | 236.17 | 232.92 | 229.89 | 190.77 | Upgrade
|
Machinery | - | 1,061 | 1,037 | 967.42 | 771.05 | 539.55 | Upgrade
|
Construction In Progress | - | 29.15 | 23.56 | 66.18 | 65.05 | 75.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.